Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Withdrawn PHASE1 INTERVENTIONAL NCT04532801

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

This study utilizes infusions of kisspeptin in healthy women to isolate the impact of kisspeptin on beta-cell responsivity assessed by the mixed meal tolerance test.

Detailed Description

Assignment: each study subject serves as their own control, and will come in timed to their cycle. The order in which they undergo the kisspeptin or placebo arms is randomized and separated by greater than two weeks to minimize variability and study-specific effects. Delivery of Interventions: Prior to each visit, study subjects will be asked to: * eat at least 150 gm carbohydrates per day * refrain from strenuous exercise On the day of the visit, study subjects will: * eat a standardized meal prepared by the metabolic kitchen in the clinical research center * be observed overnight to ensure a 12-hour fast * have an IV placed, for a 16 hour kisspeptin or placebo infusion * after the 12 hour fast, starting at 8 am in the morning will undergo a mixed meal tolerance test

Interventions

Name: Kisspeptin-10
Type: DRUG
Description: kisspeptin-10 IV infusion
Name: mixed meal tolerance test
Type: OTHER
Description: mixed meal tolerance test

Primary Outcomes

Measure: Beta-cell responsivity index
TimeFrame: up to 6 months
Description: Average beta-cell responsivity index derived from mixed meal tolerance data comparing placebo and kisspeptin arms

Trial Information

NCT ID

NCT04532801

Status

Withdrawn

Study Type

INTERVENTIONAL

Phases

PHASE1

Sponsor

Stephanie B. Seminara, MD

Last Updated

December 15, 2025